Safety & Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of Lower and Middle Rectum
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Ischemic preconditioning, Arteriogram.
- Кому может быть актуально
- Состояния в реестре: Cancer, Rectal. Базовые параметры: 18 лет — 90 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Франция
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Evaluation of the Safety and Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Oncologic Surgery for Tumors of the Lower and Middle Rectum. Bicentric Exploratory Pilot Study
Обзор
The present study will investigate the safety of inferior mesenteric artery embolization prior to rectal surgery, according to IDEAL recommendations (Lancet 2009). It aims to assess the safety of endovascular embolization of the inferior mesenteric artery prior to surgery in patients with rectal tumors, and estimate the potential benefits in terms of time to surgery and the occurrence of post-operative fistulas.The study will also assess the impact of subacute ischemia induced by IMA embolization on colonic vasculature remodeling, colonic ischemic suffering, altered hemostasis and initiation of neo-angiogenesis through blood sampling kinetics.The hypothesis is that ischemic preconditioning by inferior mesenteric artery embolization prior to rectal cancer resection surgery is safe and will result in a decrease in acute relative colon ischemia and a reduction in the rate of fistulas and post-surgical complications. Indeed, we believe that the beneficial effects of the ischemic preconditioning of IMA will be due to better blood perfusion of the colon at 3 weeks, which is apparently linked to remodeling and/or the development of collateral vascularization.
Подробное описание
Anastomotic fistulas are the main cause of morbidity and mortality in colorectal surgery. They are responsible for septic complications, leading to increased mortality, local recurrence, repeat surgery and impaired sexual, urinary and digestive function. Fistulas are multifactorial; among the causes, colonic vascularization seems to be a major one. Ligation of the inferior mesenteric artery during rectal surgery has been shown to reduce intraoperative colonic perfusion flow. The left colon is then vascularized only by the colonic border arcade, perfused by the superior mesenteric artery. Ischemic pre-conditioning of the arterial network prior to surgery should ensure better vascularization by developing arterial collaterality and increasing perfusion flow in the colonic border arcade. In view of major advances in interventional radiology, this preconditioning could be achieved by endovascular ligation of the inferior mesenteric artery (IMA), based on the same principle as during surgery: proximal occlusion of the inferior mesenteric artery (IMA), using embolization material (plug or coils), 3 weeks before surgery, to allow the colonic border arcade to develop. We carried out a single-center pilot study (AMIREMBOL 1, NIMAO 2017; Frandon et al. 2022) to assess the feasibility of ischemic preconditioning of the colon for patients with rectal or sigmoid cancer. The study included 10 patients, randomized into two groups: the control group, with preoperative arteriography and standard management and the "embolization" group, with embolization of the IMA three weeks prior to surgery. IMA embolization was successfully performed in all 5 patients in the embolization group, with no major complications. The effect on colonic perfusion, measured by intraoperative Doppler directly on the border arch, with recording of resistance indexes (independent of measurement angle), showed a drop in resistance indexes in the control arm, after ligation of the IMA, which persisted after 5 minutes. In the "Embolization" arm, no drop in this index was reported during surgery, reflecting good development of vascular collaterality and at least relative acute ischemia of the colon after IMA ligation during surgery. Finally, in the "control" group, one anastomotic fistula was reported after surgery and required re-operation. There were no fistulas in the embolization group.
The present study (AMIREMBOL 2) will investigate the safety of IMA embolization prior to rectal surgery, according to IDEAL recommendations (Lancet 2009). Its aim is to assess the safety of endovascular embolization of the IMA prior to surgery in patients with rectal tumors, and to estimate the potential benefits in terms of time to surgery and the occurrence of post-operative fistulas.
The study will also assess the impact of subacute ischemia induced by IMA embolization on colonic vasculature remodeling, colonic ischemic suffering, altered hemostasis and initiation of neo-angiogenesis through blood sampling kinetics.
The hypothesis is that ischemic preconditioning by inferior mesenteric artery (IMA) embolization prior to rectal cancer resection surgery is safe and will result in a decrease in acute relative colon ischemia and a reduction in the rate of fistulas and post-surgical complications. The hypothesis is that the beneficial effects of the ischemic preconditioning of IMA will be due to better blood perfusion of the colon at 3 weeks, which is apparently linked to remodeling and/or the development of collateral vascularization.
Вмешательства
- Процедура Ischemic preconditioning
Embolization performed via a common right femoral or radial approach, depending on the patient's conformation. Minor complications such as hematoma at the puncture site are rare in less than 1% of cases, and serious complications are exceptional. Proximal occlusion of the inferior mesenteric artery, before its dividing branches, using material adapted to arterial occlusion according to anatomical findings. Proximal occlusion during embolization is evaluated by intravascular injection into the in - Процедура Arteriogram
The interventional radiologist performs an arteriogram of the inferior and superior mesenteric arteries (IMA and SMA respectively) to check that the SMA is free of anomalies and that the IMA has a proximal trunk long enough for embolization. The radiologist also checks for the presence of a colonic border arcade. If this is absent, embolization will not be performed: the patient will be excluded from the study.This arteriogram is carried out under local anaesthetic specifically for research purp
Первичные конечные точки
- Safety of endovascular inferior mesenteric artery embolisation prior to surgical resection of the rectum in patients with tumours of the lower and middle rectum. [Срок оценки: Day 7 post embolization (performed 3 weeks before surgical resection of the rectum)]
Вторичные конечные точки (12)
- Technical success of the embolization procedure [Срок оценки: Day 0, on the day of embolization]
- Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade I [Срок оценки: Post-operative Day 30]
- Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade II [Срок оценки: Post-operative Day 30]
- Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IIIa [Срок оценки: Post-operative Day 30]
- Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IIIb [Срок оценки: Post-operative Day 30]
- Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IVa [Срок оценки: Post-operative Day 30]
- Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IVb [Срок оценки: Post-operative Day 30]
- Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade V [Срок оценки: Post-operative Day 30]
- Rate of fistulas up to 30 days after surgery [Срок оценки: Day 0]
- Rate of fistulas up to 30 days after surgery [Срок оценки: Post-operative Day 30]
- Duration of post-surgical hospitalization [Срок оценки: Up to 30 days after rectal surgery]
- Degree of difficulty experienced by the visceral surgeon during surgery [Срок оценки: Week 3 to 4 on the day of rectal surgery]
Критерии участия
Критерии включения
- Patients with rectal cancer eligible for surgery with ligation at the origin of the inferior mesenteric artery.
- Patients with free, informed consent.
- Patients affiliated to or benefiting from a health insurance plan.
Критерии исключения
- Patients with a history of colon cancer who has undergone colon resection surgery
- Patients with occlusion of the superior mesenteric artery or stenosis of more than 50%, visible on the CT scan performed as part of conventional management during extension workup.
- Patients with occlusion of the IMA on the extension scan.
- Patients with a systemic disorder responsible for haemostasis (haemophilia, Willebrand's disease, thrombocytopenia) and on anticoagulant therapy.
- Patients taking corticosteroids or immunosuppressants leading to an unacceptable surgical risk.
- Patients with renal insufficiency with clearance < 30mL/min.
- Patients with an allergy to iodine.
- Patients who has had treatment of the abdominal aorta or its branches.
- Patients participating in an interventional study.
- Patients in an exclusion period determined by another study.
- Patients under court protection, guardianship or curatorship.
- Patients unable to give consent.
- Patients for whom it is impossible to provide informed information.
- Pregnant or breast-feeding patients.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Открытое
- Основная цель
- Лечение
Центры проведения
Франция · 3 центра
- Hôpital Saint-Eloi — Montpellier
- Institut du Cancer de Montpellier — Montpellier
- CHU de Nîmes — Nîmes
Идентификаторы
NCT: NCT06236633 · NIMAO/2022-1/MB-01